1. Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C

Somatic mutations and deletions of the e-cadherin gene predict poor survival of patients with gastric cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 31: 868-75, 2013.  [Article] 

 doi: 10.1200/JCO.2012.44.4612 PMID: 23341533.

 

2. Fais S, O'Driscoll L, Borras FE, Buzas E, Camussi G, Cappello F, Carvalho J, Cordeiro da Silva A, Del Portillo H, El Andaloussi S, Ficko Trcek T, Furlan R, Hendrix A, Gursel I, Kralj-Iglic V, Kaeffer B, Kosanovic M, Lekka ME, Lipps G, Logozzi M, Marcilla A, Sammar M, Llorente A, Nazarenko I, Oliveira C, Pocsfalvi G, Rajendran L, Raposo G, Rohde E, Siljander P, van Niel G, Vasconcelos MH, Yáñez-Mó M, Yliperttula ML, Zarovni N, Zavec AB, Giebel B

Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine. ACS nano 10: 3886-99, 2016.  [Editorial Material] 

 doi: 10.1021/acsnano.5b08015 PMID: 26978483.

 

3. Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carriço R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmão L, Wen X, Cipriano MA, Yokota J, Carneiro F, Huntsman D, Seruca R

Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 136: 2137-48, 2009.  [Article] 

 doi: 10.1053/j.gastro.2009.02.065 PMID: 19269290.

 

4. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Simões-Correia J, Oliveira MJ, Pinheiro H, Pinho SS, Mateus R, Reis CA, Leite M, Fernandes MS, Schmitt F, Carneiro F, Figueiredo C, Oliveira C, Seruca R

Epithelial E- and P-cadherins: Role and clinical significance in cancer. Biochimica et Biophysica acta-Reviews on Cancer 1826: 297-311, 2012.  [Review] 

 doi: 10.1016/j.bbcan.2012.05.002 PMID: 22613680.

 

5. Pinheiro H, Bordeira-Carriço R, Seixas S, Carvalho J, Senz J, Oliveira P, Inácio P, Gusmão L, Rocha J, Huntsman D, Seruca R, Oliveira C

Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Human molecular genetics 19: 943-52, 2010.  [Article] 

 doi: 10.1093/hmg/ddp537. PMID: 19965908.

 

6. Pinheiro H, Carvalho J, Oliveira P, Ferreira D, Pinto MT, Osório H, Licastro D, Bordeira-Carriço R, Jordan P, Lazarevic D, Sanges R, Stupka E, Huntsman D, Seruca R, Oliveira C

Transcription initiation arising from E-cadherin/CDH1 intron2: a novel protein isoform that increases gastric cancer cell invasion and angiogenesis. Human molecular genetics 21: 4253-69, 2012.  [Article] 

 doi: 10.1093/hmg/dds248 PMID: 22752307.

 

7. Carvalho J, van Grieken NC, Pereira PM, Sousa S, Tijssen M, Buffart TE, Diosdado B, Grabsch H, Santos MA, Meijer G, Seruca R, Carvalho B, Oliveira C

Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. The Journal of pathology 228: 31-44, 2012.  [Article] 

 doi: 10.1002/path.4032 PMID: 22450781.

 

8. Karam R, Carvalho J, Bruno I, Graziadio C, Senz J, Huntsman D, Carneiro F, Seruca R, Wilkinson MF, Oliveira C

The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers. Oncogene 27: 4255-60, 2008.  [Article] 

 doi: 10.1038/onc.2008.62 PMID: 18427545.

 

9. Santos M, Pereira PM, Varanda AS, Carvalho J, Azevedo M, Mateus DD, Mendes N, Oliveira P, Trindade F, Pinto MT, Bordeira-Carriço R, Carneiro F, Vitorino R, Oliveira C, Santos MAS

Codon misreading tRNAs promote tumor growth in mice. RNA biology 15: 773-786, 2018.  [Article] 

 doi: 10.1080/15476286.2018.1454244 PMID: 29558247.

 

10. Carneiro P, Figueiredo J, Bordeira-Carriço R, Fernandes MS, Carvalho J, Oliveira C, Seruca R

Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. Expert opinion on therapeutic targets 17: 1187-201, 2013.  [Review] 

 doi: 10.1517/14728222.2013.827174 PMID: 23957294.

 

11. Oliveira P, Carvalho J, Rocha S, Azevedo M, Reis I, Camilo V, Sousa B, Valente S, Paredes J, Almeida R, Huntsman D, Oliveira C

Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation. Scientific reports 6: 34860, 2016.  [Article] 

 doi: 10.1038/srep34860 PMID: 27721458.

 

12. Gullo I, Carvalho J, Martins D, Lemos D, Monteiro AR, Ferreira M, Das K, Tan P, Oliveira C, Carneiro F, Oliveira P

The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors. International journal of molecular sciences 19: ., 2018.  [Article] 

 doi: 10.3390/ijms19072079 PMID: 30018250.

 

13. Carneiro P, Fernandes MS, Figueiredo J, Caldeira J, Carvalho J, Pinheiro H, Leite M, Melo S, Oliveira P, Simões-Correia J, Oliveira MJ, Carneiro F, Figueiredo C, Paredes J, Oliveira C, Seruca R

E-cadherin dysfunction in gastric cancer - Cellular consequences, clinical applications and open questions. FEBS letters 586: 2981-9, 2012.  [Review] 

 doi: 10.1016/j.febslet.2012.07.045 PMID: 22841718.

 

14. Oliveira C, Sousa S, Pinheiro H, Bordeira-Carrico R, Carvalho J, Carneiro F, Huntsman D, Seruca R

Quantification of Epigenetic and Genetic Second Hits in CDH1 During Hereditary Diffuse Gastric Cancer Syndrome Progression Helicobacter 14: 383-383, 2009.  [Meeting Abstract] 

.

 

15. Pinheiro HC, Carrico R, Carvalho J, Oliveira P, Gusmao L, Seixas S, Rocha J, Huntsman D, Seruca R, Oliveira C

Allele-Specific CDH1 Downregulation Increases Susceptibility to Diffuse Gastric Cancer Helicobacter 14: 381-381, 2009.  [Meeting Abstract] 

.

 

16. Corso G, Sousa S, Pedrazzani C, Marrelli D, Carvalho J, Pinheiro H, Seruca R, Roviello F, Oliveira C

Systematic Study of CDH1 Inactivation in Human Gastric Cancer Helicobacter 14: 330-330, 2009.  [Meeting Abstract] 

.

 

17. Lima JF, Carvalho J, Pinto-Ribeiro I, Almeida C, Wengel J, Cerqueira L, Figueiredo C, Oliveira C, Azevedo NF

Targeting miR-9 in gastric cancer cells using locked nucleic acid oligonucleotides. BMC molecular biology 19: 6, 2018.  [Article] 

 doi: 10.1186/s12867-018-0107-6 PMID: 29879907.

 

18. Queirós P, Pinheiro H, Carvalho J, Oliveira P, Gullo I, Carneiro F, Almeida GM, Oliveira C

KRAS mutations in microsatellite instable gastric tumours: impact of targeted treatment and intratumoural heterogeneity. Virchows Archiv : an international journal of pathology 467: 383-92, 2015.  [Article] 

 doi: 10.1007/s00428-015-1823-7 PMID: 26318594.

 

19. Lopes N, Carvalho J, Durães C, Sousa B, Gomes M, Costa JL, Oliveira C, Paredes J, Schmitt F

1alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1 promoter demethylation Anticancer research  1, 2012.  [] 

 PMID: 22213313.

 

20. Yáñez-Mó M, Siljander PR, Andreu Z, Zavec AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, Colás E, Cordeiro-da Silva A, Fais S, Falcon-Perez JM, Ghobrial IM, Giebel B, Gimona M, Graner M, Gursel I, Gursel M, Heegaard NH, Hendrix A, Kierulf P, Kokubun K, Kosanovic M, Kralj-Iglic V, Krämer-Albers EM, Laitinen S, Lässer C, Lener T, Ligeti E, Line A, Lipps G, Llorente A, Lötvall J, Mancek-Keber M, Marcilla A, Mittelbrunn M, Nazarenko I, Nolte-'t Hoen EN, Nyman TA, O'Driscoll L, Olivan M, Oliveira C, Pállinger É, Del Portillo HA, Reventós J, Rigau M, Rohde E, Sammar M, Sánchez-Madrid F, Santarém N, Schallmoser K, Ostenfeld MS, Stoorvogel W, Stukelj R, Van der Grein SG, Vasconcelos MH, Wauben MH, De Wever O

Biological properties of extracellular vesicles and their physiological functions. Journal of extracellular vesicles 4: 27066, 2015.  [Review] 

 doi: 10.3402/jev.v4.27066 PMID: 25979354.

 

21. Hansford S, Kaurah P, Li-Chang H, Woo M, Senz J, Pinheiro H, schrader K, Schaeffer DF, Shumansky K, Zogopoulos G, Almeida Santos T, Claro I, Carvalho J, Nielsen C, Padilla S, Lum A, Talhouk A, Baker-Lange K, Richardson S, Lewis I, Lindor N, Pennell E, MacMillan A, Fernandez B, Keller G, Lynch H, Shah S, Guilford P, Gallinger S, Corso G, Roviello F, Caldas C, Oliveira C, Pharoah P, Huntsman D

Hereditary Diffuse Gastric Cancer Syndrome CDH1 Mutations and Beyond JAMA Oncology  1, 2014.  [Article] 

 doi: 10.1001/jamaoncol.2014.168.

 

22. Carvalho J, Oliveira C

Extracellular Vesicles - Powerful Markers of Cancer EVolution. Frontiers in immunology 5: 685, 2014.  [Editorial Material] 

 doi: 10.3389/fimmu.2014.00685 PMID: 25628624.